Osman D. Suleymanov

Pharmacological Interruption of Acute Thrombus Formation with Minimal Hemorrhagic Complications by a Small Molecule Tissue Factor/Factor VIIa Inhibitor: Comparison to Factor Xa and Thrombin Inhibition in a Nonhuman Primate Thrombosis Model

Osman D. Suleymanov, James A. Szalony, Anita K. Salyers et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 64 citations

Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time

James A. Szalony, Osman D. Suleymanov, Anita K. Salyers et al. · Thrombosis Research · 2003 · 37 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +12

Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist

Nancy S. Nicholson, Norman Abood, Susan G. Panzer‐Knodle et al. · Medicinal Research Reviews · 2001 · 26 citations

The Protective Dose of the Potent GPIIb/IIIa Antagonist SC-54701A Is Reduced When Used in Combination With Aspirin and Heparin in a Canine Model of Coronary Artery Thrombosis

Leo G. Frederick, Osman D. Suleymanov, Lucy W. King et al. · Circulation · 1996 · 21 citations

Potassium prorenoate: a new steroidal aldosterone antagonist.

Lorenz M. Hofmann, Leland J. Chinn, H A Pedrera et al. · Journal of Pharmacology and Experimental Therapeutics · 1975 · 21 citations